Assessment of the perception of the public on the impact of the lockdown due to the Coronavirus Disease 2019 (COVID-19)

Autor: Awofisayo O, Ologunagba MO, Williams FE, Joda AE, Ibrahim MB, Olugbake OA, Ayeni FA, Oyetunde OO, Mosanya AU

Publikováno v: Ibom Medical Journal, Vol 15, Iss 1 (2022)

Background: Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2 started in Wuhan, China in December 2019 and was declared pandemic by the World Health Organization (WHO) in March 2020. Globally, majority of nations worldwide with Nigeria inclusi

Externí odkaz: https://doaj.org/article/2b07135712234369b2778c3a55b76257

Correction: Lactic acid bacteria isolated from women' breast milk and infants' faeces have appreciable immunogenic and probiotic potentials against diarrheagenic E. coli strains.

Autor: Obisesan AO; Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Ibadan, Oyo State, Nigeria.; Department of Pharmaceutical Microbiology and Biotechnology, College of Pharmacy, Afe Babalola University, Ado Ekiti, Nigeria., Abiodun OO; Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Ibadan, Ibadan, Oyo State, Nigeria., Ayeni FA; Department of Environmental and Occupational Health, School of Public Health, Indiana University Bloomington, Bloomington, IN, USA. fayeni@iu.edu.

Publikováno v: BMC microbiology [BMC Microbiol] 2024 Sep 27; Vol. 24 (1), pp. 363. Date of Electronic Publication: 2024 Sep 27.

Changes in the gut microbiota of Nigerian infants within the first year of life.

Autor: Oyedemi OT; Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria., Shaw S; Centre for Genome Enabled Biology and Medicine, University of Aberdeen, Aberdeen, Scotland, United Kingdom., Martin JC; The Rowett Institute, University of Aberdeen, Aberdeen, Scotland, United Kingdom., Ayeni FA; Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria.; Department of Biology, Simmons University, Fenway, Boston, United States of America., Scott KP; The Rowett Institute, University of Aberdeen, Aberdeen, Scotland, United Kingdom.

Publikováno v: PloS one [PLoS One] 2022 Mar 17; Vol. 17 (3), pp. e0265123. Date of Electronic Publication: 2022 Mar 17 (Print Publication: 2022).

Lactobacillus crispatus thrives in pregnancy hormonal milieu in a Nigerian patient cohort.

Autor: Odogwu NM; Pan African University Life and Earth Sciences Institute (PAULESI), University of Ibadan, Ibadan, Oyo State, Nigeria. nkechiodogwu27@gmail.com.; Division of Surgical Research, Department of Surgery, Mayo Clinic, Rochester, MN, USA. nkechiodogwu27@gmail.com.; Microbiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA. nkechiodogwu27@gmail.com.; Department of Obstetrics and Gynecology, College of Medicine, University of Ibadan, Ibadan, Nigeria. nkechiodogwu27@gmail.com., Onebunne CA; Department of Obstetrics and Gynecology, University College Hospital, Ibadan, Nigeria., Chen J; Microbiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.; Department of Health Science Research, Mayo Clinic, Rochester, MN, USA., Ayeni FA; Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria., Walther-Antonio MRS; Division of Surgical Research, Department of Surgery, Mayo Clinic, Rochester, MN, USA.; Microbiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.; Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA., Olayemi OO; Department of Obstetrics and Gynecology, University College Hospital, Ibadan, Nigeria.; Department of Obstetrics and Gynecology, College of Medicine, University of Ibadan, Ibadan, Nigeria., Chia N; Division of Surgical Research, Department of Surgery, Mayo Clinic, Rochester, MN, USA. Chia.Nicholas@mayo.edu.; Microbiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA. Chia.Nicholas@mayo.edu.; Department of Health Science Research, Mayo Clinic, Rochester, MN, USA. Chia.Nicholas@mayo.edu.; Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Chia.Nicholas@mayo.edu., Omigbodun AO; Department of Obstetrics and Gynecology, University College Hospital, Ibadan, Nigeria.; Department of Obstetrics and Gynecology, College of Medicine, University of Ibadan, Ibadan, Nigeria.

Publikováno v: Scientific reports [Sci Rep] 2021 Sep 13; Vol. 11 (1), pp. 18152. Date of Electronic Publication: 2021 Sep 13.

Predominance of Atopobium vaginae at Midtrimester: a Potential Indicator of Preterm Birth Risk in a Nigerian Cohort.

Autor: Odogwu NM; Pan African University Life and Earth Sciences Institute (PAULESI), University of Ibadan, Ibadan, Nigeria nkechiodogwu27@gmail.com Chia.Nicholas@mayo.edu.; Division of Surgical Research, Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA.; Microbiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Department of Obstetrics and Gynecology, College of Medicine, University of Ibadan, Ibadan, Nigeria., Chen J; Microbiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Department of Health Science Research, Mayo Clinic, Rochester, Minnesota, USA., Onebunne CA; Department of Obstetrics and Gynecology, University College Hospital, Ibadan, Nigeria., Jeraldo P; Division of Surgical Research, Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA.; Microbiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA., Yang L; Microbiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Department of Health Science Research, Mayo Clinic, Rochester, Minnesota, USA., Johnson S; Microbiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Department of Health Science Research, Mayo Clinic, Rochester, Minnesota, USA., Ayeni FA; Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria., Walther-Antonio MRS; Division of Surgical Research, Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA.; Microbiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Department of Obstetrics & Gynecology, Mayo Clinic, Rochester, Minnesota, USA., Olayemi OO; Department of Obstetrics and Gynecology, University College Hospital, Ibadan, Nigeria.; Department of Obstetrics and Gynecology, College of Medicine, University of Ibadan, Ibadan, Nigeria., Chia N; Division of Surgical Research, Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA nkechiodogwu27@gmail.com Chia.Nicholas@mayo.edu.; Microbiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Department of Health Science Research, Mayo Clinic, Rochester, Minnesota, USA.; Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA., Omigbodun AO; Department of Obstetrics and Gynecology, University College Hospital, Ibadan, Nigeria.; Department of Obstetrics and Gynecology, College of Medicine, University of Ibadan, Ibadan, Nigeria.

Publikováno v: MSphere [mSphere] 2021 Jan 27; Vol. 6 (1). Date of Electronic Publication: 2021 Jan 27.